A few months ago, India’s drug regulator Central Drugs Standard Control Organization (CDSCO) approved the commercial use of CAR-T cell therapy. Therapy involves genetically reprogramming the patient’s immune system to fight the cancer.
Read Next
National
December 3, 2024
Over 25 injured as bus overturns in MP's Chhindwara
National
December 3, 2024
ED raids in Bengal over medical admission irregularities
National
December 3, 2024
Cyclone Fengal: Yellow alert in 15 districts of Tamil Nadu
December 3, 2024
Over 25 injured as bus overturns in MP's Chhindwara
December 3, 2024
Couple jumps to death from third floor of building in Visakhapatnam
December 3, 2024
Cyclone Fengal: PM Modi dials CM Stalin, assures all possible help
December 3, 2024
ED raids in Bengal over medical admission irregularities
December 3, 2024
Cyclone Fengal: Yellow alert in 15 districts of Tamil Nadu
December 3, 2024
One terrorist killed in ongoing gunfight in J&K’s Srinagar (Ld)
December 3, 2024
AAP leader Raghav Chadha seeks RS debate on decline of law and order in Delhi
December 3, 2024
After govt-Oppn reach consensus, both Houses set to resume sessions today
December 3, 2024
Delhi records AQI of 274, air quality continues to remain 'poor'
December 3, 2024